Respiratory Syncytial Virus in Older Adults: Setting the Foundation

Download All
In this series of concise Medical Minute videos with companion podcasts, commentaries, and a living downloadable slide set, hear experts discuss key strategies for evaluating the risk of severe outcomes due to RSV in older adults and the latest data from ongoing prevention research.
Dexter James Wiseman, MD

Medical Minutes

Learn from a leading expert about RSV in older adults, including epidemiology and reasons older adults are at increased risk compared with their younger counterparts.

Dexter James Wiseman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 8, 2022 Expired: No longer available for credit

Learn from a leading expert about RSV in older adults, including epidemiology and reasons older adults are at increased risk compared with their younger counterparts.

Dexter James Wiseman, MD Released: April 8, 2022

Learn from a leading expert about strategies for overcoming difficulties related to the diagnosis and impact of RSV in older adults.

Dexter James Wiseman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 13, 2022 Expired: No longer available for credit

Learn from a leading expert about strategies for overcoming difficulties related to the diagnosis and impact of RSV in older adults.

Dexter James Wiseman, MD Released: April 13, 2022

Learn from a leading expert about RSV immunology and the current status of the most promising vaccines in development for older adults.

Dexter James Wiseman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 6, 2022 Expired: No longer available for credit

Learn from a leading expert about RSV immunology and the current status of the most promising vaccines in development for older adults.

Dexter James Wiseman, MD Released: April 6, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings